# Adult-onset Still’s disease during pregnancy: two case reports and a comprehensive literature review

**Authors:** Wenchao Xu, Shuang Huang, Juanli Li, Ting Li, Yu Lu, Liu Yang, Jianyu Zhang, Xue Li, Jian Chen

PMC · DOI: 10.3389/fmed.2025.1588300 · 2025-07-09

## TL;DR

This paper discusses two cases of rare inflammatory disease diagnosed during pregnancy and highlights the need for careful management to ensure good outcomes for both mother and baby.

## Contribution

The paper presents two new case reports of AOSD diagnosed during pregnancy and emphasizes the importance of multidisciplinary care.

## Key findings

- AOSD can be triggered or diagnosed during pregnancy, requiring careful treatment.
- Multidisciplinary management is essential to ensure favorable maternal and fetal outcomes.
- Treatment with methylprednisolone and cyclosporine was effective in managing symptoms during pregnancy.

## Abstract

Adult-onset Still’s disease (AOSD) is a rare systemic inflammatory disorder marked by recurrent fever, rash, arthritis, and multi-organ involvement. Its occurrence with pregnancy complicates diagnosis and management.

To present the diagnosis and treatment process of two pregnant patients with newly diagnosed AOSD.

Two cases of AOSD were initially diagnosed during pregnancy. Case one involved a pregnant woman at 16 + 2 weeks of gestation with recurrent fevers, rash, and myalgia. She responded well to treatment with methylprednisolone and cyclosporine and subsequently had a normal vaginal delivery. Case two involved a pregnant woman at 30 + 6 weeks of gestation who presented with systemic joint pain and fever. After being diagnosed with AOSD, she underwent a cesarean section. Treatment included methylprednisolone, cyclosporine, and addition of methotrexate postpartum.

Adult-onset Still’s disease can be triggered by pregnancy, requiring a multidisciplinary approach for optimal management and fetal outcomes.

## Linked entities

- **Chemicals:** methylprednisolone (PubChem CID 6741), cyclosporine (PubChem CID 5284373), methotrexate (PubChem CID 4112)
- **Diseases:** Adult-onset Still’s disease (MONDO:0019355), arthritis (MONDO:0005578)

## Full-text entities

- **Diseases:** fever (MESH:D005334), rash (MESH:D005076), joint pain (MESH:D018771), systemic inflammatory disorder (MESH:D018746), AOSD (MESH:D016706), myalgia (MESH:D063806), arthritis (MESH:D001168)
- **Chemicals:** methylprednisolone (MESH:D008775), cyclosporine (MESH:D016572), methotrexate (MESH:D008727)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12283597/full.md

---
Source: https://tomesphere.com/paper/PMC12283597